vimarsana.com

Page 25 - தேசிய நிறுவனம் ஆஃப் நரம்பியல் கோளாறுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine by J&J comes with rare nerve syndrome warning Here s what to know about it

COVID-19 vaccine by J&J comes with rare nerve syndrome warning Here s what to know about it
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

CDC says J&J vaccine has small possible risk of rare neurological disorder

CDC says J&J vaccine has ‘small possible risk’ of rare neurological disorder By Kelly Hayes U.S. health officials said Monday Johnson & Johnson’s COVID-19 vaccine may pose a small possible risk of a rare neurological disorder known as Guillain-Barré syndrome, another setback for the vaccine that was temporarily paused earlier this year.  About 100 suspected cases of Guillain-Barré syndrome were identified out of 12.8 million doses of the Johnson & Johnson shot, according to a statement from the U.S. Centers for Disease Control and Prevention. The cases were mostly reported about two weeks after vaccination and mostly in men, age 50 and older, the CDC said. 

UCR scientists receive additional federal funding to boost research on brain injury

UCR scientists receive additional federal funding to boost research on brain injury Earlier this year, Viji Santhakumar, an associate professor of molecular, cell and systems biology at the University of California, Riverside, received funding from the National Institute of Neurological Disaster and Stroke of the National Institutes of Health, or NIH, to further pursue research on moderate concussive brain injury. Now three scientists in her lab have received federal funding no small achievement for a university research group. Department of Defense award Deepak Subramanian, a postdoctoral researcher, has received a three-year Department of Defense Idea Development Award of $466,000 to examine the molecular and immune axis of neurological deficits in posttraumatic epilepsy. The project starts July 15.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.